US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.27

+0.82002.03%

Post-market: 41.270.00000.00%18:39 EDT

Volume:1.26M

Turnover:52.12M

Market Cap:1.06B

PE:- -

High:41.37

Open:40.60

Low:40.60

Close:40.45

52wk High:43.52

52wk Low:28.77

Shares:25.80M

Float Shares:25.80M

Volume Ratio:15.04

T/O Rate:4.90%

Dividend:0.29

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Genmab at 3-Year High After Blood Cancer Drug Combination Study Results

Tech Coast Angels Reports Profitable Atraverse Medical Exit After Johnson & Johnson Acquisition, Citing 70%+ IRR

L'Oreal Explores Unloading Chemical-Related Liabilities, WSJ Reports

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Bristol-Myers Squibb Co: Prelim Total Acquired Iprd and Licensing Income $1,536 Mln for Three Months Ended September 30, 2026

THOMSON REUTERS

AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense

Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing

THOMSON REUTERS

Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing

THOMSON REUTERS

Abbvie Inc. Fy2026 Shr View $14.02

THOMSON REUTERS

Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing

THOMSON REUTERS

Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer

MT Newswires Live

Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL

AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study

Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study

Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL

Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl

THOMSON REUTERS

Genmab: Safety Profile of Epcoritamab When Administered in Combination with Standard of Care R-Chop was Generally Well Tolerated

THOMSON REUTERS

Genmab and Abbvie Announce Epcoritamab in Combination with R-Chop Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

THOMSON REUTERS

Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/FTXH/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FTXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","market":"US","secType":"STK","nameCN":"First Trust Nasdaq Pharmaceuticals ETF","latestPrice":41.27,"timestamp":1791576000000,"preClose":40.45,"halted":0,"volume":1263440,"hourTrading":{"tag":"盘后","latestPrice":41.27,"preClose":41.27,"latestTime":"18:39 EDT","volume":685055,"amount":28272142.39,"timestamp":1791585556641,"change":0,"changeRate":0,"amplitude":0.003392},"delay":0,"changeRate":0.020271940667490735,"floatShares":25800002,"shares":25800002,"eps":0,"marketStatus":"Market Closed","change":0.82,"latestTime":"10-09 16:00:00 EDT","open":40.6,"high":41.37,"low":40.6,"amount":52122476.824159995,"amplitude":0.019036,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":40.45,"sharesOutstanding":850002,"nav":40.46,"aum":1045891080.92,"dividendRate":0.007056,"bidAskSpread":0.001333,"preHourTrading":{"tag":"盘前","latestPrice":40.45,"preClose":40.45,"latestTime":"07:38 EDT","volume":1,"amount":40.45,"timestamp":1791545911139,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":41.27,"preClose":41.27,"latestTime":"18:39 EDT","volume":685055,"amount":28272142.39,"timestamp":1791585556641,"change":0,"changeRate":0,"amplitude":0.003392},"volumeRatio":15.04134634604464,"impliedVol":0.216,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","floatShares":25800002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":15.04134634604464,"shares":25800002,"dividePrice":0.2912,"high":41.37,"amplitude":0.019036,"preClose":40.45,"low":40.6,"week52Low":28.77,"pbRate":"--","week52High":43.52,"institutionHeld":0,"latestPrice":41.27,"eps":0,"divideRate":0.007056,"volume":1263440,"delay":0,"ttmEps":0,"open":40.6,"prevYearClose":32.9401,"prevWeekClose":40.73,"prevMonthClose":41.47,"prevQuarterClose":41.47,"fiveDayClose":40.73,"twentyDayClose":40.4666,"sixtyDayClose":38.5244},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTXH\",params:#limit:5,,,undefined,":[{"date":"2026-09-24","symbol":"FTXH","amount":0.0113,"announcedDate":"2026-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-24","defaultRemindTime":1790256600000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-30","payableDate":"2026-09-24","currency":"USD","dateTimestamp":1790222400000,"payDate":"2026-09-30"},{"date":"2026-06-25","symbol":"FTXH","amount":0.092,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FTXH","amount":0.0573,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FTXH","amount":0.1294,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FTXH","amount":0.1453,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTXH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0056,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0286,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-03-31","value":0.0313,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0553,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.3448,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTXH\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673103450","title":"Genmab at 3-Year High After Blood Cancer Drug Combination Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2673103450","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673103450?lang=en_us&edition=fundamental","pubTime":"2026-10-06 15:18","pubTimestamp":1791271123,"startTime":"0","endTime":"0","summary":"BUZZ-Genmab at 3-year high after blood cancer drug combination study results** Shares in GenmabGMAB.COrise around 8%to their highest in three years, hitting top of STOXX 600.STOXXindex** Genmab and Ab","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL8N45S0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","IE0000B7K699.USD","LU0859254822.USD","LU0868494617.USD","LU2129689514.USD","LU1934455863.HKD","BK4139","LU1929549753.HKD","LU2237443622.USD","TRUH","JDOC","VHT","LU0211328371.USD","RXL","ABBV","IYH","MEDX","IXJ","SG9999001440.SGD","IE00B42XCP33.USD","LU0203345920.USD","LU0256863811.USD","AGNG","IE000MB6IJN5.SGD","LU1989772923.USD","PPH","FHLC","LU1732799900.SGD","GLAM","LU0456855351.SGD","LU0417517546.SGD","LU2357305700.SGD","SG9999003800.SGD","PJP","LU1732800096.USD","LU0965509010.AUD","LU1244550494.USD","LU0795875086.SGD","LU1037948541.HKD","LU0708994859.HKD","LU0472753341.HKD","BK4550","IE00BDGV0183.EUR","LU0882574055.USD","LU0912757837.SGD","IE00BSNM7G36.USD","LU0942090050.USD","XLV","FTXH","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673080374","title":"Tech Coast Angels Reports Profitable Atraverse Medical Exit After Johnson & Johnson Acquisition, Citing 70%+ IRR","url":"https://stock-news.laohu8.com/highlight/detail?id=2673080374","media":"Reuters","labels":["shareholding","corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673080374?lang=en_us&edition=fundamental","pubTime":"2026-10-06 08:05","pubTimestamp":1791245145,"startTime":"0","endTime":"0","summary":"Tech Coast Angels reports profitable Atraverse Medical exit after Johnson & Johnson acquisition, citing 70%+ IRRTech Coast Angels reported a profitable exit from Atraverse Medical following its acquis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL17Q5Wq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","FTXH","LU0345770308.USD","LU1059921491.USD","IE000M9KFDE8.USD","RXL","LU0912757837.SGD","LU2750360641.GBP","LU0985320562.USD","LU1291159041.SGD","SG9999002232.USD","LU1732800096.USD","FHLC","LU2471134796.USD","LU1228905037.USD","IE00BSNM7G36.USD","LU2417539215.USD","GDOC","LU2505996681.GBP","BMED","LU1244550494.USD","BK4585","LU0124676726.USD","LU0466842654.USD","LU1066051225.USD","LU1221951129.SGD","LU0882574055.USD","IXJ","BK4532","LU0345769128.USD","LU1935042991.SGD","LU2403377893.USD","LU2430703095.HKD","MEDX","JDOC","LU0122379950.USD","LU2430703178.SGD","IHE","XLV","IE00BFXG1179.USD","PJP","LU1894683348.USD","IE000BZT7R73.USD","LU0787776722.HKD","LU2236285917.USD","TRUH","VHT","JNJ","LU0820562030.AUD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673829530","title":"L'Oreal Explores Unloading Chemical-Related Liabilities, WSJ Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2673829530","media":"Reuters","labels":["event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673829530?lang=en_us&edition=fundamental","pubTime":"2026-10-06 05:36","pubTimestamp":1791236175,"startTime":"0","endTime":"0","summary":"UPDATE 2-L'Oreal explores unloading chemical-related liabilities, WSJ reportsOct 5 (Reuters)-L'OrealOREP.PAhas engaged restructuring advisers to explore options for rising US legal liabilities linked ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL6N45R14J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0787776722.HKD","IYH","FTXH","IE00BFXG1179.USD","LU0820561818.USD","XLV","LU0912757837.SGD","LU1032466523.USD","LU0640476718.USD","LU1228905037.USD","LU0689626769.HKD","LU0289961442.SGD","FHLC","LU2023250330.USD","LU0072461881.USD","SGXZ57979304.SGD","IXJ","LU2403377893.USD","LU2430703251.USD","JNJ","PJP","MEDX","IE00B3PB1722.GBP","IE00BKVL7J92.USD","LU0964807845.USD","LU0545039389.USD","VHT","LU0289739343.SGD","IE00B19Z3B42.SGD","TRUH","LU1074936037.SGD","LU0949170772.SGD","LU2430703178.SGD","SG9999002224.SGD","LU2505996509.AUD","LU1551013342.USD","LU0545562505.USD","IHE","LU0889566641.SGD","GDOC","JDOC","IE00BSNM7G36.USD","RXL","BK4504","LU2112291526.USD","LU0203347892.USD","BMED","HONG","LU1023059063.AUD","HON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084910","title":"Medtronic PLC Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084910","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084910?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:38","pubTimestamp":1791232680,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  advanced 1.84% to $87.97 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.Medtronic PLC closed 17.27% short of its 52-week high of $106.33, which the company reached on November 26th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Danaher Corp.  rose 3.34% to $221.21, and Abbott Laboratories  rose 2.67% to $100.10.Trading volume  eclipsed its 50-day average volume of 10.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABT","LU0070302665.USD","MDT","SG9999013999.USD","LU1778281490.HKD","IE00BKVL7J92.USD","LU1718418525.SGD","IE0004445239.USD","LU2063271972.USD","FMED","VHT","TRUH","LU1066051225.USD","LU2430703095.HKD","JDOC","LU0211326839.USD","BMED","LU1989763427.SGD","LU1145028129.USD","IHE","LU1061106388.HKD","SG9999001176.SGD","FHLC","DHR","LU1280957306.USD","GDOC","SG9999001176.USD","LU0058720904.USD","LU0345770308.USD","LU2125909593.SGD","JNJ","LU1983299246.USD","LU1674673691.USD","LU0943347566.SGD","IYH","LU1923622614.USD","LU0122379950.USD","RXL","FTXH","XLV","IXJ","LU0006306889.USD","LU1003077747.HKD","PJP","TMED","SGXZ57979304.SGD","LU0314106906.USD","MEDX","IE00B3PB1722.GBP","IHI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084323","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084323?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:31","pubTimestamp":1791232260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  advanced 1.12% to $265.76 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.This was the stock's second consecutive day of gains.AbbVie Inc. closed 1.35% short of its 52-week high of $269.39, which the company achieved on September 23rd.The stock outperformed some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Pfizer Inc.  fell 1.40% to $27.41, and Amgen Inc.  fell 0.01% to $402.98.Trading volume  eclipsed its 50-day average volume of 4.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000SO60NU8.SGD","LU0965509010.AUD","IE000WAW04H5.SGD","LU0823416689.USD","SG9999001440.SGD","LU1093756325.SGD","LU1718418525.SGD","BK4566","LU0689472784.USD","LU1934455863.HKD","LU1732799900.SGD","LU1934455194.USD","IE00BLSP4452.SGD","PPH","SG9999011175.SGD","IE0000B7K699.USD","SG9999015952.SGD","LU0472753341.HKD","LU1267930573.SGD","LU1496350171.SGD","LU0170899867.USD","BK4550","IE00BDGV0183.EUR","LU2357627491.SGD","JDOC","LU0738911758.USD","IE00BJT1NW94.SGD","LU0211328371.USD","FHLC","IE00BVYPNV92.GBP","BK4585","SG9999015978.USD","LU1244550221.USD","LU0289961442.SGD","LU1057294990.SGD","LU2237443895.HKD","LU0882574055.USD","LU0198837287.USD","GLAM","LU0545039389.USD","XLV","LU1236620750.USD","IE000MB6IJN5.SGD","LU2237443978.SGD","LU0114720955.EUR","LU1093756168.USD","LU0661504455.SGD","LU0456855351.SGD","LU0912757837.SGD","IXJ","RXL","LU1839511570.USD","BK4533","IE00B4R5TH58.HKD","LU1551013425.SGD","LU1061106388.HKD","LU2347655073.USD","LU0795875169.SGD","LU0158827948.USD","LU0432979614.USD","IE00BN8TJ469.HKD","TRUH","LU0124676726.USD","LU0310799852.SGD","LU1934455277.USD","LU1720051108.HKD","LU1989772923.USD","LU0965509283.SGD","IE00B19Z3B42.SGD","LU2347655156.SGD","LU0256863902.USD","LU0203345920.USD","LU0795875086.SGD","IYH","BK4139","FTXH","LU2237443549.SGD","LU1989771016.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","LU0289739343.SGD","LU2133065610.SGD","SG9999015945.SGD","IE00B42XCP33.USD","LU2125909593.SGD","LU1074936037.SGD","LU0965508806.USD","LU0289739699.SGD","LU0320765646.SGD","LU2089984988.USD","LU1244550494.USD","IE00B3PB1722.GBP","LU2089284900.SGD","LU0211327993.USD","LU0868494617.USD","LU0511384066.AUD","LU1923622614.USD","LU0029864427.USD","BK4581","LU0256863811.USD","LU1430594728.SGD","LU2129689605.HKD","LU2089283258.USD","IE00BLSP4239.USD","IE00BVYPNW00.USD","LU0868494708.USD","IE00BJJMRZ35.SGD","LU1037948541.HKD","LU1003077747.HKD","IE00BBT3K403.USD","MEDX","LU2112291526.USD","LU0820561909.HKD","BK4534","LU2237443465.HKD","LU1496350502.SGD","LU2468319806.SGD","IE0009355771.USD","LU0069063385.USD","LU0234572021.USD","LU2237443382.USD","IE00B19Z3581.USD","LU0128525929.USD","LU0708994859.HKD","LU1236620834.HKD","VHT","AGNG","LU2129689514.USD","LU0203347892.USD","PJP","LU1670627923.USD","LU1548497426.USD","ABBV","LU0310800379.SGD","LU1929549753.HKD","LU0726765562.USD","LU1267930490.SGD","LU1244550577.SGD","LU1585245621.USD","BK4588","IE00B2B36J28.USD","IE0004445239.USD","LU2237443622.USD","SG9999003800.SGD","LU1162221912.USD","LU1732800096.USD","LU0395794307.EUR","LU2129689431.USD","BK4559","LU0689626769.HKD","IE00BSNM7G36.USD","LU0098860793.USD","LU0965509101.SGD","IE000F7OJYX1.SGD","LU1720051017.SGD","LU1670628061.USD","LU0942090050.USD","LU0417517546.SGD","LU2357305700.SGD","IE0002141913.USD","LU2433249047.HKD","LU2023251221.USD","IE0002270589.USD","LU2125909247.SGD","LU1983299246.USD","LU1291159041.SGD","LU2087621335.USD","LU0234570918.USD","IE00BGHQF631.EUR","LU0057025933.USD","LU0058720904.USD","LU0949170772.SGD","LU1023059063.AUD","LU1037948897.HKD","SG9999015986.USD","LU1989772840.SGD","IE000BZT7R73.USD","LU0820561818.USD","LU0553294199.USD","LU0985320562.USD","LU0861579265.USD","LU1551013342.USD","LU0859254822.USD","LU0943347566.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084883","title":"Bristol-Myers Squibb Co: Prelim Total Acquired Iprd and Licensing Income $1,536 Mln for Three Months Ended September 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084883?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:21","pubTimestamp":1791231689,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1093756168.USD","BK4534","LU0225284248.USD","LU0456855351.SGD","IE00BJJMRZ35.SGD","LU0237698245.USD","LU1670711123.USD","LU1868836591.USD","BMY","LU1883839398.USD","LU1032466523.USD","BK4007","LU1670711040.USD","LU0096364046.USD","LU0868494617.USD","BK4585","LU1983299246.USD","LU2125154778.USD","BK4559","BK4581","LU1718418525.SGD","LU1291159041.SGD","LU2133065610.SGD","IE0009355771.USD","LU0321505439.SGD","IE0002141913.USD","LU1868836757.USD","IE00B2B36J28.USD","LU1323610961.USD","LU0985481810.HKD","LU2596442595.SGD","LU1868836914.USD","BK4588","IE00BFTCPJ56.SGD","IHE","LU0321505868.SGD","LU0882574055.USD","LU1670710661.SGD","LU2360032135.SGD","LU1261432733.SGD","LU2242652126.USD","FTXH","LU0061475181.USD","LU0306806265.USD","LU1093756325.SGD","BK4532","LU1236620834.HKD","LU1670710588.SGD","LU1868837136.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081209","title":"AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081209","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081209?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:09","pubTimestamp":1791230948,"startTime":"0","endTime":"0","summary":"AbbVie cuts Q3 adjusted diluted EPS outlook to $3.73-$3.77 after $216 million acquired IPR&D, milestones expenseAbbVie cut Q3 2026 adjusted diluted EPS guidance to USD 3.73–3.77 from USD 3.84–3.88, re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLbW9K2t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","SG9999015978.USD","FTXH","MEDX","IE0002141913.USD","LU0943347566.SGD","FHLC","PJP","ABBV","IE00BGHQF631.EUR","LU0122379950.USD","BK4534","LU0170899867.USD","LU1732799900.SGD","BK4588","IE000BZT7R73.USD","LU1720051108.HKD","LU1037948541.HKD","LU0553294199.USD","IE00B3PB1722.GBP","LU0234570918.USD","BK4566","AGNG","GLAM","LU1236620750.USD","LU2237443978.SGD","LU0320765646.SGD","JDOC","LU1934455863.HKD","IE000SO60NU8.SGD","IE00BDGV0183.EUR","BK4550","LU0128525929.USD","RXL","IXJ","LU0203345920.USD","TRUH","LU1236620834.HKD","VHT","IYH","LU2023251221.USD","LU1267930573.SGD","LU1430594728.SGD","PPH","LU0158827948.USD","XLV","LU0661504455.SGD","LU1162221912.USD","IE0004445239.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673812780","title":"Abbvie - Full-Year 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $13.76-$13.96 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673812780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673812780?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B3PB1722.GBP","LU1732799900.SGD","LU0234570918.USD","IE0004445239.USD","SG9999015978.USD","LU0170899867.USD","VHT","LU0158827948.USD","IYH","LU1934455863.HKD","RXL","ABBV","TRUH","FHLC","LU0943347566.SGD","GLAM","LU1236620750.USD","LU0661504455.SGD","IE000SO60NU8.SGD","LU0122379950.USD","BK4566","LU1037948541.HKD","BK4588","LU0320765646.SGD","MEDX","BK4534","IE0002141913.USD","FTXH","IE000BZT7R73.USD","LU1430594728.SGD","LU0553294199.USD","PJP","LU2237443978.SGD","LU1720051108.HKD","XLV","LU1267930573.SGD","JDOC","IE00BGHQF631.EUR","BK4550","LU1585245621.USD","IXJ","IE00BDGV0183.EUR","AGNG","LU0203345920.USD","LU1162221912.USD","LU0128525929.USD","LU1023059063.AUD","PPH","LU2023251221.USD","LU1236620834.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673220081","title":"Abbvie - Q3 2026 Gaap and Adj Earnings Include $216 Mln Bought Ipr&D and Milestones Expense - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673220081","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673220081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1244550577.SGD","RXL","IE00BGHQF631.EUR","LU1496350502.SGD","LU1267930573.SGD","TRUH","LU1061106388.HKD","LU2237443978.SGD","LU0417517546.SGD","LU1551013425.SGD","LU0689626769.HKD","LU0158827948.USD","LU0545039389.USD","GLAM","LU0058720904.USD","LU0708994859.HKD","BK4581","LU0738911758.USD","IXJ","LU0823416689.USD","LU0553294199.USD","AGNG","LU1003077747.HKD","LU0203347892.USD","FTXH","IE00BSNM7G36.USD","LU0211327993.USD","BK4534","LU0661504455.SGD","LU1585245621.USD","FHLC","XLV","PJP","LU2129689431.USD","IYH","JDOC","VHT","PPH","LU2237443895.HKD","LU0114720955.EUR","LU0912757837.SGD","LU0795875169.SGD","ABBV","LU0795875086.SGD","LU1720051017.SGD","LU2357305700.SGD","LU2087621335.USD","MEDX","LU0124676726.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081273","title":"Abbvie Inc. Fy2026 Shr View $14.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081273?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","AGNG","LU0256863902.USD","LU1989772923.USD","FHLC","LU2125909593.SGD","IE00BJT1NW94.SGD","LU0057025933.USD","FTXH","XLV","LU1057294990.SGD","IE00B3PB1722.GBP","TRUH","LU1983299246.USD","LU1732799900.SGD","LU0738911758.USD","ABBV","BK4581","PJP","JDOC","LU1061106388.HKD","LU2237443622.USD","SG9999003800.SGD","LU2125909247.SGD","MEDX","LU0122379950.USD","LU0859254822.USD","LU2237443465.HKD","RXL","LU0203345920.USD","LU0098860793.USD","LU0965509010.AUD","IXJ","LU1003077747.HKD","IE0004445239.USD","PPH","IYH","VHT","LU0943347566.SGD","LU1923622614.USD","LU0417517546.SGD","LU1267930573.SGD","LU1093756168.USD","LU2347655073.USD","LU1720051108.HKD","LU1718418525.SGD","SG9999015952.SGD","GLAM","SG9999015978.USD","LU2237443549.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081227","title":"Abbvie - Q3 2026 Adj Diluted EPS Guidance Range Including Bought Ipr&D is $3.73-$3.77 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081227","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081227?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:08","pubTimestamp":1791230913,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1JK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1074936037.SGD","LU0395794307.EUR","IE00B3PB1722.GBP","LU2237443622.USD","LU1929549753.HKD","LU2237443382.USD","ABBV","LU0511384066.AUD","LU2089283258.USD","JDOC","IXJ","SG9999001440.SGD","PJP","LU1037948897.HKD","LU2125909593.SGD","LU0256863811.USD","LU0689472784.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU1496350502.SGD","LU0472753341.HKD","LU1244550221.USD","LU0949170772.SGD","VHT","LU2112291526.USD","XLV","BK4581","FTXH","GLAM","LU1236620750.USD","MEDX","LU1839511570.USD","AGNG","LU1718418525.SGD","FHLC","TRUH","LU2237443465.HKD","LU0058720904.USD","IE00BN8TJ469.HKD","LU0170899867.USD","LU1023059063.AUD","BK4534","LU1934455194.USD","LU2347655073.USD","LU0289961442.SGD","IYH","LU0861579265.USD","PPH","RXL","IE00BLSP4452.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673819760","title":"Genmab, AbbVie Say New Drug Combo Helps Lymphoma Patients Stay Cancer-Free Longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2673819760","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673819760?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:50","pubTimestamp":1791229824,"startTime":"0","endTime":"0","summary":"Genmab  and AbbVie  said that adding their drug epcoritamab to a standard chemotherapy mix helped people with an aggressive form of blood cancer stay cancer-free longer than chemotherapy alone.The combination cut the risk of the cancer getting worse or the patient dying by 51% compared with standard treatment alone, the companies said Monday in a statement. Results were from a large study in newly diagnosed patients with diffuse large B-cell lymphoma, the most common type of non-Hodgkin lymphoma.The treatment paired epcoritamab with R-CHOP, a long-used chemotherapy regimen. The companies said the safety of the combination looked generally similar to what doctors already expect from each drug on its own.Because the treatment is still experimental, Genmab and AbbVie plan to meet with regulators around the world to discuss next steps.Genmab shares rose 11% in Monday trading, and AbbVie gained 1.3%.Price: 38.72, Change: +3.97, Percent Change: +11.41","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1162221912.USD","LU2089284900.SGD","LU0965509101.SGD","PPH","JDOC","LU0395794307.EUR","LU2237443382.USD","GMAB","LU0256863811.USD","TRUH","MEDX","SG9999003800.SGD","RXL","BK4581","GLAM","LU2125909593.SGD","LU2347655156.SGD","ABBV","LU1989772840.SGD","SG9999015945.SGD","LU0128525929.USD","LU0942090050.USD","PJP","IE00BSNM7G36.USD","IE00BLSP4239.USD","LU2237443549.SGD","LU2347655073.USD","FTXH","XLV","LU0158827948.USD","IE00BN8TJ469.HKD","IYH","IE00BVYPNW00.USD","AGNG","FHLC","LU0795875169.SGD","VHT","LU1244550221.USD","LU2089283258.USD","LU2129689605.HKD","LU1839511570.USD","LU1983299246.USD","LU2237443465.HKD","LU1923622614.USD","LU0689626769.HKD","IE00B4R5TH58.HKD","LU1057294990.SGD","IXJ","IE000MB6IJN5.SGD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673811030","title":"Genmab and AbbVie Report Landmark Phase 3 Win for Epcoritamab Combo in Frontline DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673811030","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673811030?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:47","pubTimestamp":1791229638,"startTime":"0","endTime":"0","summary":"An announcement from Genmab ( ($GMAB) ) is now available. Genmab and AbbVie reported on October 5, 2026, that their Phase 3 EPCORE DLBCL-2 trial sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmab-and-abbvie-report-landmark-phase-3-win-for-epcoritamab-combo-in-frontline-dlbcl?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1236620750.USD","AGNG","LU0158827948.USD","MEDX","FTXH","LU2468319806.SGD","LU1037948541.HKD","IE00BDGV0183.EUR","LU1037948897.HKD","TRUH","IE000SO60NU8.SGD","BK4581","LU1929549753.HKD","ABBV","VHT","LU1670628061.USD","BK4585","LU0965509283.SGD","LU0689626769.HKD","FHLC","LU2357305700.SGD","LU0122379950.USD","IE000F7OJYX1.SGD","IE00B4R5TH58.HKD","LU1551013342.USD","RXL","LU1718418525.SGD","XLV","IXJ","LU1074936037.SGD","LU2089284900.SGD","BK4550","BK4559","JDOC","GLAM","IE00B3PB1722.GBP","LU2237443465.HKD","IYH","LU2237443382.USD","LU0823416689.USD","PJP","LU1496350502.SGD","LU0289739699.SGD","LU1720051017.SGD","PPH","LU2237443978.SGD","LU0965509101.SGD","LU1244550221.USD","LU0456855351.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673363081","title":"AbbVie Blood Cancer Drug Combo Cuts Risk of Progression or Death in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673363081","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673363081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 03:36","pubTimestamp":1791228977,"startTime":"0","endTime":"0","summary":"AbbVie blood cancer drug combo cuts risk of progression or death in late-stage studyOct 5 (Reuters)-Danish biotech firm GenmabGMAB.COand US drugmaker AbbVieABBV.Nsaid on Monday their combination treat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL4N45R185:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU0256863811.USD","LU0942090050.USD","RXL","BK4581","LU0795875169.SGD","VHT","LU0128525929.USD","SG9999003800.SGD","IE000MB6IJN5.SGD","LU1162221912.USD","IE00BN8TJ469.HKD","IXJ","ABBV","LU2237443382.USD","LU0859254822.USD","TRUH","MEDX","IE00BVYPNW00.USD","LU0965509101.SGD","LU2125909593.SGD","IYH","GLAM","IE00BFTCPJ56.SGD","LU2089284900.SGD","LU0689626769.HKD","LU1989772840.SGD","FHLC","LU1839511570.USD","LU2237443465.HKD","LU2129689605.HKD","LU2347655073.USD","LU0158827948.USD","FTXH","LU1923622614.USD","LU2089283258.USD","LU2237443549.SGD","LU2347655156.SGD","XLV","LU1057294990.SGD","IE00BSNM7G36.USD","IE00B4R5TH58.HKD","PPH","SG9999015945.SGD","JDOC","LU1244550221.USD","LU1983299246.USD","AGNG","LU0395794307.EUR","IE00BLSP4239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673311081","title":"Genmab, AbbVie report epcoritamab combination demonstrates improved PFS in study","url":"https://stock-news.laohu8.com/highlight/detail?id=2673311081","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673311081?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:55","pubTimestamp":1791226515,"startTime":"0","endTime":"0","summary":"Genmab A/S (GMAB) and AbbVie (ABBV) announced “positive” topline results from the Phase 3 EPCORE DLBCL-2 trial evaluating fixed treatment duration ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genmab-abbvie-report-epcoritamab-combination-demonstrates-improved-pfs-in-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABBV","LU1934455277.USD","LU0128525929.USD","LU1551013342.USD","LU2433249047.HKD","LU2023251221.USD","FHLC","LU0289739699.SGD","LU2125909593.SGD","LU1585245621.USD","LU0057025933.USD","XLV","LU0256863902.USD","LU0726765562.USD","LVIG","MEDX","LU0069063385.USD","LU0868494617.USD","LU2357627491.SGD","IYH","GMAB","VHT","AGNG","JDOC","LU0456855351.SGD","LU1496350171.SGD","RXL","LU2089284900.SGD","TRUH","SG9999001440.SGD","GLAM","LU0211328371.USD","LU0203345920.USD","LU1074936037.SGD","IXJ","LU1934455194.USD","LU0058720904.USD","LU0417517546.SGD","LU1267930490.SGD","LU1720051108.HKD","LU0511384066.AUD","IE00BJT1NW94.SGD","PPH","PJP","SG9999015986.USD","IE000MB6IJN5.SGD","LU1023059063.AUD","LU0395794307.EUR","FTXH","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089429","title":"Genmab Says Phase 3 Epcore DLBCL-2 Trial Shows Epcoritamab Plus R-CHOP Cuts Progression or Death Risk 51% in Newly Diagnosed DLBCL","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089429","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089429?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:50","pubTimestamp":1791226259,"startTime":"0","endTime":"0","summary":"Genmab says Phase 3 EPCORE DLBCL-2 trial shows epcoritamab plus R-CHOP cuts progression or death risk 51% in newly diagnosed DLBCLGenmab, AbbVie reported positive topline Phase 3 results for epcoritam","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLWBPbl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","JDOC","GLAM","LU0158827948.USD","IE00B2B36J28.USD","IE00BGHQF748.EUR","LU0912757837.SGD","LU0234570918.USD","LU0114720955.EUR","LU0943347566.SGD","LU0310799852.SGD","LU0882574055.USD","IXJ","IE00BJT1NW94.SGD","IE000SO60NU8.SGD","AGNG","LU2468319806.SGD","BCDF","TRUH","PJP","IE00BKPKM429.USD","ABBV","IE00BN0W2V16.EUR","IYH","IE00B19Z3B42.SGD","RXL","VHT","IE00BQXX3F31.USD","BK4581","IE00B19Z3581.USD","LU1923622614.USD","NDAQ","LU0289961442.SGD","PPH","LU1003077747.HKD","LU1720051017.SGD","BK4550","LU2089283258.USD","IE000WAW04H5.SGD","LU0859254822.USD","LU1585245621.USD","LU0198837287.USD","FTXH","BK4588","XLV","LU1989771016.USD","LU1023059063.AUD","LU0320765646.SGD","LU2095319765.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673894940","title":"Genmab - Phase 3 Trial Shows 51% Reduction in Risk of Progression or Death in Dlbcl","url":"https://stock-news.laohu8.com/highlight/detail?id=2673894940","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673894940?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1003077747.HKD","LU1551013425.SGD","IE0000B7K699.USD","LU0234570918.USD","LU0859254822.USD","IE00B2B36J28.USD","LU0553294199.USD","TRUH","JDOC","IE000SO60NU8.SGD","VHT","LU0289961442.SGD","BK4581","RXL","ABBV","IYH","MEDX","IXJ","BK4588","IE00B19Z3B42.SGD","AGNG","IE000WAW04H5.SGD","PPH","LU2468319806.SGD","LU1023059063.AUD","FHLC","GLAM","LU0320765646.SGD","LU0456855351.SGD","LU0198837287.USD","PJP","IE00BJT1NW94.SGD","LU0965509010.AUD","LU1720051017.SGD","LU1267930573.SGD","LU2089283258.USD","LU0158827948.USD","LU0310799852.SGD","LU1923622614.USD","LU1989771016.USD","BK4550","LU0114720955.EUR","LU0882574055.USD","IE00BBT3K403.USD","LU0912757837.SGD","LU1585245621.USD","XLV","FTXH","LU0943347566.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673894110","title":"Genmab: Safety Profile of Epcoritamab When Administered in Combination with Standard of Care R-Chop was Generally Well Tolerated","url":"https://stock-news.laohu8.com/highlight/detail?id=2673894110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673894110?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0708994859.HKD","FHLC","JDOC","GLAM","LU1551013425.SGD","LU0234570918.USD","LU0256863811.USD","LU0417517546.SGD","LU0456855351.SGD","IXJ","IE00BJT1NW94.SGD","SG9999015952.SGD","AGNG","TRUH","LU2023251221.USD","PJP","ABBV","IYH","LU0128525929.USD","LU0738911758.USD","LU1934455194.USD","RXL","BK4534","VHT","LU2357627491.SGD","LU0795875169.SGD","LU0861579265.USD","LU0868494617.USD","LU1244550577.SGD","LU1934455277.USD","LU0965509101.SGD","PPH","LU2129689605.HKD","BK4550","LU0689626769.HKD","LU1037948541.HKD","LU0949170772.SGD","IE00BVYPNV92.GBP","IE00BJJMRZ35.SGD","LU0256863902.USD","LU1989772923.USD","FTXH","XLV","BK4559","LU2237443382.USD","BK4566","LU0795875086.SGD","LU1548497426.USD","IE0004445239.USD","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673089491","title":"Genmab and Abbvie Announce Epcoritamab in Combination with R-Chop Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2673089491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673089491?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:49","pubTimestamp":1791226144,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089284900.SGD","LU1093756168.USD","BK4585","LU0965509101.SGD","PPH","JDOC","LU1585245621.USD","LU2237443382.USD","LU0820561909.HKD","TRUH","LU2129689514.USD","LU0868494708.USD","MEDX","IE000SO60NU8.SGD","RXL","LU1037948897.HKD","LU2089984988.USD","GLAM","LU0689472784.USD","ABBV","LU1989772840.SGD","PJP","LU2087621335.USD","FTXH","LU1720051108.HKD","XLV","LU0320765646.SGD","IYH","IE00B19Z3B42.SGD","IE00BVYPNW00.USD","AGNG","FHLC","LU1551013342.USD","VHT","IE00B3PB1722.GBP","LU0868494617.USD","LU2129689605.HKD","LU1267930573.SGD","LU2112291526.USD","LU1923622614.USD","IE000BZT7R73.USD","LU1934455863.HKD","LU0511384066.AUD","LU1934455277.USD","IXJ","LU1023059063.AUD","LU1267930490.SGD","LU0823416689.USD","LU1236620750.USD","LU2433249047.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673408917","title":"Eli Lilly Stock (LLY) Gains on Regulatory Win for Experimental Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2673408917","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673408917?lang=en_us&edition=fundamental","pubTime":"2026-10-06 02:35","pubTimestamp":1791225314,"startTime":"0","endTime":"0","summary":"The stock of Eli Lilly ($LLY) is up about 1% on Oct. 5 after the company secured a regulatory win for one of its experimental cancer drugs called O...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gains-on-regulatory-win-for-experimental-cancer-drug?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-gains-on-regulatory-win-for-experimental-cancer-drug?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2023250504.SGD","LU2361044865.SGD","SGXZ81514606.USD","LU2750360997.AUD","BK4534","IE00BKDWB100.SGD","LU2360106947.USD","LU2896262040.SGD","LU0823416689.USD","LU0061475181.USD","LU0122379950.USD","LU0198837287.USD","BK4581","GB00BDT5M118.USD","IE00BK4W5L77.USD","LU1720051017.SGD","SGXZ51526630.SGD","SGXZ31699556.SGD","CANC","LU2236285917.USD","LU0266013472.USD","LU0353189680.USD","HRTS","LU0158827781.USD","IE00BJT1NW94.SGD","LU0225283273.USD","LU2462591350.SGD","IXJ","IE00B1BXHZ80.USD","LU0432979614.USD","LU2168564222.USD","LU1551013342.USD","LU1983299246.USD","LU0345770308.USD","LU1917777945.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BWXC8680.SGD","LU0345770993.USD","CURE","LU2417539215.USD","LU1035775433.USD","IE00B1XK9C88.USD","LU0787776722.HKD","TMED","SG9999015945.SGD","AGNG","BK4588","IE00BKPKM429.USD","LU2237443382.USD","LU0820562030.AUD","LU2265009873.SGD","LU1868836757.USD","SG9999014880.SGD","LU2746668461.USD","LU1691799644.USD","LU0320765992.SGD","LU1551013425.SGD","BK4007","XLV","LU2461242641.AUD","SG9999013999.USD","LU2756315318.SGD","LU0238689110.USD","SGXZ57979304.SGD","BK4599","LU2111349929.HKD","LU2112291526.USD","FTXH","LU0820561909.HKD","LU2211815571.USD","LU2471134952.CNY","LU0640476718.USD","LU0683600562.USD","LU2361045086.USD","LU0889565916.HKD","LU1548497426.USD","SG9999017495.SGD","LU1814569148.SGD","LU1868836591.USD","LU1974910355.USD","WDNA","LU1868836914.USD","IE00B4JS1V06.HKD","LU0256863811.USD","LU1868837136.USD","LU2491050154.USD","LU1720051108.HKD","SG9999014906.USD","LU1804176565.USD","IE00BK4W5M84.HKD","LU0943347566.SGD","IE00BFSS7M15.SGD","SG9999018857.SGD","BK4533","PPH","LU0354030511.USD","LU2237438978.USD","LU1989771016.USD","LU0471298694.HKD","LU2552382058.USD","IE00BJJMRY28.SGD","IE0005OL40V9.USD","LU0109391861.USD","LU0354030438.USD","LU1623119135.USD","ELIL","LU0133085943.USD","LU2089284900.SGD","LU1868837300.USD","LU2213496289.HKD","BK4516","LU2468319806.SGD","LU2237443549.SGD","LLY","LU2471134879.HKD","THNR","LU0114720955.EUR","LU1069344957.HKD","LU1323610961.USD","LU2168564149.EUR","IE00BJJMRX11.SGD","LU2491050071.SGD","LU2089984988.USD","LU1064131342.USD","IE00BJLML261.HKD","LU2168564495.EUR","LU0234572021.USD","GDOC","IE00BFTCPJ56.SGD","LU2106854487.HKD","LU0174119429.USD","LU2750360641.GBP","LU2456880835.USD","LU1127390331.HKD","LU0708995401.HKD","TRUH","SG9999014898.SGD","LU1057294990.SGD","LU2168563687.JPY","LU0079474960.USD","LLII","IE00B4R5TH58.HKD","LU1712237335.SGD","LU0417517546.SGD","SGXZ99366536.SGD","LU1988902786.USD","LU2357305700.SGD","PJP","LU0820561818.USD","LU2237443978.SGD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU2602419157.SGD","LU0385154629.USD","LU2462157665.USD","MEDI","JDOC","LU2089283258.USD","IE0001KFT4U8.USD","LU0289739699.SGD","LU2063271972.USD","LU2108987350.USD","IE0004445015.USD","ILDR","LU0316494557.USD","LU1093756325.SGD","LU2264538146.SGD","LLYZ","LU0096364046.USD","LLYX","LU0094547139.USD","LU0471298777.SGD","LU0823434583.USD","LU1093756168.USD","IE0004445239.USD","LU0964807845.USD","MHIP","LU0256863902.USD","LU2237443895.HKD","LU1629891620.HKD","LU0106261372.USD","LU1232071149.USD","ELIS","LU0323591593.USD","LU0882574055.USD","LU2023250330.USD","LU2271345857.HKD","LU0456855351.SGD","IHE","LU0006306889.USD","LU0320765059.SGD","LU0672654240.SGD","LU1366192091.USD","LU2028103732.USD","LU1280957306.USD","LU0466842654.USD","LU2552382132.HKD","LU0882574139.USD","LU2168564065.EUR","IE00BFSS8Q28.SGD","SG9999015986.USD","LU2237443465.HKD","LU0097036916.USD","LU0689472784.USD","LU2087625088.SGD","LU2471134523.USD","VHT","LU0058720904.USD","BK4585","IYH","LU0353189763.USD","LU1291159041.SGD","LU1979441026.SGD","LU1061106388.HKD","LU0823434740.USD","LU1267930730.SGD","LU2324357040.USD","LU0203201768.USD","LU2746668974.SGD","MEDX","IE00B7KXQ091.USD","IE00B775H168.HKD","OZEM","LU0203202063.USD","SG9999001176.USD","SG9999015978.USD","FHLC","SG9999014914.USD","LU2552382215.SGD","LU2361044949.HKD","LU2756315664.SGD","LU2023251221.USD","LU0109394709.USD","LU2237443622.USD","LU2491049909.HKD","RXL","LU1023059063.AUD","LU0158827948.USD","SG9999015952.SGD","SG9999018865.SGD","SG9999001176.SGD","IE00BN29S564.USD","LU0786609619.USD","IE0009355771.USD","LU2471134796.USD","LU0210536198.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":6,"totalSize":318,"code":"91000000","status":"200"}]}}